FOXA1 and breast carcinoma: A recent examination of FOXA1 mutations in >4950 breast tumors and metastatic lesions found that 4.18% of breast cancers and 4.88% of metastases harbored recurring mutations, with the majority occurring in the Wing2 subdomain, consistent with previous reports [88,89,90].